arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Acurx Pharmaceuticals, Inc.

ACXP

$1.37 0.00 (0.00%) at close

26 Visible periods

17 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Acurx Pharmaceuticals, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.8M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -22.4% ↘

FCF / Share $-0.40 ↗

Trailing P/E —

Price / Book 0.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-1.68M

↑ +21.8% —

FCF / Share Free cash flow per share

$-0.40

↑ +22.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
EPS Growth YoY (%)	72.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	71.8% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	90.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	63.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	60.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	57.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	28.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	7.0% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-12.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-35.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	25.0% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-7.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	3.8% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-27.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	30.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	-23.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-37.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-119.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	21.8% Good ↓ Good Declining Year-over-year change in net income	21.8% Good ↓ Good Declining Year-over-year change in net income	43.3% Excellent ↓ Excellent Declining Year-over-year change in net income	50.9% Excellent → Excellent Stable Year-over-year change in net income	50.9% Excellent ↑ Excellent Improving Year-over-year change in net income	50.9% Excellent ↑ Excellent Improving Year-over-year change in net income	45.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-50.8% Weak → Weak Stable Year-over-year change in net income	-50.8% Weak ↓ Weak Declining Year-over-year change in net income	-50.8% Weak ↓ Weak Declining Year-over-year change in net income	-56.9% Weak ↓ Weak Declining Year-over-year change in net income	-8.7% Weak ↑ Weak Improving Year-over-year change in net income	-8.7% Weak ↑ Weak Improving Year-over-year change in net income	-8.7% Weak ↑ Weak Improving Year-over-year change in net income	-24.1% Weak ↑ Weak Improving Year-over-year change in net income	-81.1% Weak ↑ Weak Improving Year-over-year change in net income	-81.1% Weak → Weak Stable Year-over-year change in net income	-81.1% Weak ↓ Weak Declining Year-over-year change in net income	-140.3% Weak ↓ Weak Declining Year-over-year change in net income	-15.3% Weak Weak Year-over-year change in net income	-15.3% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	74.7% Excellent Excellent Year-over-year change in free cash flow	—	56.8% Excellent Excellent Year-over-year change in free cash flow	—	48.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-19.2% Weak Weak Year-over-year change in free cash flow	—	—	—	9.4% Fair Fair Year-over-year change in free cash flow	—	—	—	-130.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
FCF / Net Income (x)	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.67x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.70x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Return on Invested Capital (%)	-22.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-50.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	—	-358.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-83.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-95.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-21.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-33.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-72.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-20.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	-24.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	-30.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-300%)	-59.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-494%)	-60.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-502%)	-93.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-720%)	—	-164.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1196%)	-127.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-952%)	-73.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-587%)	-109.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-831%)	-73.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-592%)	-46.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-411%)	-54.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-464%)	-44.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-397%)	-27.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	—	—	-21.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Net Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$-14.46M	$-17.10M	—	—	$-3.41M	$-1.97M	$-2.48M

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Basic EPS, GAAP (USD)	$-0.53	$-0.62	$-0.31	$-1.23	$-1.89	$-2.20	$-3.22	$-3.45	$-5.21	$-5.60	$-7.60	$-4.80	$-5.60	$-5.00	$-5.60	$-6.40	$-5.20	$-5.20	$-4.40	$-9.20	—	$-4.20	$-3.20	$-4.20	—	—
Free Cash Flow per Share (USD)	$-0.40	$-0.52	—	$-1.16	—	$-2.05	—	$-2.68	$-3.64	$-3.96	—	—	—	$-3.32	—	—	—	$-3.67	—	—	—	$-1.59	—	$-2.42	—	—
Book Value per Share (USD)	$1.74	$2.07	$2.24	$2.02	$2.43	$2.06	$0.72	$3.26	$4.33	$7.61	$6.45	$6.05	$9.56	$9.10	$12.58	$16.84	—	—	$24.30	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$1.74	$2.07	$2.24	$2.02	$2.43	$2.06	$0.72	$3.26	$4.33	$7.61	$6.45	$6.05	$9.56	$9.10	$12.58	$16.84	—	—	$24.30	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	4.26M	2.72M	—	1.63M	1.19M	1.00M	—	818,174	791,233	773,625	—	650,256	609,324	581,970	—	557,420	513,160	511,642	—	505,820	—	343,364	—	313,329	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Working Capital (USD)	—	—	—	—	$3.57M	$2.31M	—	—	—	—	—	$3.93M	$6.22M	$5.31M	—	$9.76M	$8.74M	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$8.15M	$7.01M	$5.27M	$3.64M	$3.57M	$2.31M	$615.12K	$2.66M	$3.43M	$6.00M	$4.67M	$3.93M	$6.22M	$5.31M	$7.32M	$9.76M	—	—	$12.41M	—	—	—	—	—	—	—

📋 What is driving earnings? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Net Income, GAAP (USD)	$-1.68M	$-1.68M	$-1.58M	$-2.15M	$-2.15M	$-2.15M	$-2.78M	$-4.38M	$-4.38M	$-4.38M	$-5.11M	$-2.90M	$-2.90M	$-2.90M	$-3.26M	$-2.67M	$-2.67M	$-2.67M	$-2.63M	$-1.47M	$-1.47M	$-1.47M	$-1.09M	$-1.28M	$-1.28M	—
Operating Cash Flow (USD)	$-1.71M	$-1.41M	$-1.18M	$-1.88M	—	$-2.05M	$-2.25M	$-2.19M	$-2.88M	$-3.06M	$-4.20M	—	—	$-1.93M	$-1.50M	—	—	$-1.88M	$-1.50M	—	—	$-547.14K	$-959.75K	$-758.76K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 26 quarters

Acurx Pharmaceuticals, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ACXP with peers